N P Hurst

2.5k total citations · 1 hit paper
47 papers, 1.9k citations indexed

About

N P Hurst is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, N P Hurst has authored 47 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 13 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in N P Hurst's work include Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). N P Hurst is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). N P Hurst collaborates with scholars based in United Kingdom, Australia and Denmark. N P Hurst's co-authors include Danny Ruta, Paul Kind, Mary M. Hunter, G. Nuki, Alison Lochhead, Maureen Hunter, Paresh Jobanputra, Helen Brown, Michelle Lambert and Charles Lambert and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

N P Hurst

46 papers receiving 1.8k citations

Hit Papers

Measuring health-related quality of life in rheumatoid ar... 1997 2026 2006 2016 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N P Hurst United Kingdom 20 576 323 271 255 233 47 1.9k
Rob Riemsma United Kingdom 22 287 0.5× 194 0.6× 234 0.9× 181 0.7× 150 0.6× 51 1.8k
Sylvain Mathieu France 26 1.1k 1.9× 208 0.6× 300 1.1× 337 1.3× 210 0.9× 92 2.4k
Marja Blom Finland 27 465 0.8× 266 0.8× 218 0.8× 562 2.2× 145 0.6× 55 2.2k
Andrew P. Yu United States 33 433 0.8× 476 1.5× 719 2.7× 673 2.6× 254 1.1× 80 3.7k
Antonio Addis Italy 25 137 0.2× 290 0.9× 373 1.4× 344 1.3× 124 0.5× 121 2.7k
Beth Nordstrom United States 23 213 0.4× 167 0.5× 151 0.6× 205 0.8× 183 0.8× 80 2.8k
Anne Lethaby New Zealand 45 388 0.7× 77 0.2× 165 0.6× 853 3.3× 185 0.8× 94 7.0k
Stanley B. Kaplan United States 15 1.0k 1.8× 61 0.2× 350 1.3× 200 0.8× 423 1.8× 21 2.3k
Samuel Whittle Australia 24 662 1.1× 62 0.2× 177 0.7× 310 1.2× 178 0.8× 94 1.6k
Zulma Ortiz Argentina 15 286 0.5× 128 0.4× 58 0.2× 167 0.7× 146 0.6× 35 1.6k

Countries citing papers authored by N P Hurst

Since Specialization
Citations

This map shows the geographic impact of N P Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N P Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N P Hurst more than expected).

Fields of papers citing papers by N P Hurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N P Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N P Hurst. The network helps show where N P Hurst may publish in the future.

Co-authorship network of co-authors of N P Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of N P Hurst. A scholar is included among the top collaborators of N P Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N P Hurst. N P Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hurst, N P. (2000). Does waiting matter? A randomized controlled trial of new non-urgent rheumatology out-patient referrals. British journal of rheumatology. 39(4). 369–376. 13 indexed citations
3.
Hurst, N P & Euan McRorie. (1998). The short-term health outcome of out-patient rheumatology consultations in relation to rationing: a pilot study. Lara D. Veeken. 37(5). 509–513. 5 indexed citations
4.
Hurst, N P, Danny Ruta, & Paul Kind. (1998). Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. Lara D. Veeken. 37(8). 862–869. 187 indexed citations
5.
6.
Lambert, Charles & N P Hurst. (1995). HEALTH ECONOMICS AS AN ASPECT OF HEALTH OUTCOME: BASIC PRINCIPLES AND APPLICATION IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 34(8). 774–780. 22 indexed citations
7.
Jobanputra, Paresh, et al.. (1995). AN AUDIT OF METHOTREXATE AND FOLIC ACID FOR RHEUMATOID ARTHRITIS. EXPERIENCE FROM A TEACHING CENTRE. Lara D. Veeken. 34(10). 971–975. 12 indexed citations
8.
Lambert, Charles, et al.. (1994). A PILOT STUDY OF THE ECONOMIC COST AND CLINICAl OUTCOME OF DAY PATIENT VS INPATIENT MANAGEMENT OF ACTIVE RHEUMATOID ARTHRITIS. Lara D. Veeken. 33(4). 383–388. 19 indexed citations
9.
Hurst, N P. (1990). Stress (heat shock) proteins and rheumatic disease. Rheumatology International. 9(6). 271–276. 16 indexed citations
10.
Hurst, N P, et al.. (1989). Auranofin modulates human neutrophil superoxide production and protein phosphorylation. Rheumatology International. 8(6). 245–250. 10 indexed citations
11.
Forbes, Ian J., Peter D. Zalewski, N P Hurst, C. Giannakis, & M. W. Whitehouse. (1989). Zinc increases phorbol ester receptors in intact B‐cells, neutrophil polymorphs and platelets. FEBS Letters. 247(2). 445–447. 26 indexed citations
12.
Murray, AW, et al.. (1988). Enhancement of Protein Kinase C-mediated EGF Receptor Phosphorylation by Auranofin. Scandinavian Journal of Rheumatology. 17(4). 281–285. 6 indexed citations
14.
Bell, A. L., N P Hurst, & G. Nuki. (1986). EFFECT OF CORTICOSTEROID THERAPY ON BLOOD MONOCYTE SUPEROXIDE GENERATION IN RHEUMATOID ARTHRITIS: STUDIES IN VITRO AND EX VIVO. Lara D. Veeken. 25(4). 366–371. 7 indexed citations
15.
Fleck, Brian W., A. L. Bell, John D. Mitchell, et al.. (1985). Screening for antimalarial maculopathy in rheumatology clinics.. BMJ. 291(6498). 782–785. 8 indexed citations
16.
Hurst, N P, et al.. (1985). Inhibition of phospholipid transmethylation and methylation dependent superoxide anion production in human monocytes by antimalarial drugs. Lara D. Veeken. 24(2). 206. 1 indexed citations
18.
Hurst, N P, et al.. (1983). Coxsackie B infection and arthritis.. BMJ. 286(6365). 605.1–605. 18 indexed citations
19.
Ford, Michael, N P Hurst, & G. Nuki. (1983). Reactive Arthritis—Infectious Agents and Genetic Susceptibility in the Pathogenesis of Sero-Negative Arthritis. Scottish Medical Journal. 28(1). 34–41. 3 indexed citations
20.
Rosalki, Sidney B. & N P Hurst. (1976). Transient presence in serum of an atypical alkaline phosphatase. Clinica Chimica Acta. 73(1). 149–155. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026